Companies People Investors Funding Rounds Acquisitions Schools Events Hubs Saved Edico Genome, Amazon Web Services Partner on Cloud Bioinformatics . "Edico Genome has grown from a startup with a big idea to the leading secondary genomic analysis solution provider," said Pieter van Rooyen, Ph.D., president and CEO at Edico Genome. Search Crunchbase. Page Transparency See More. The DRAGEN Genome Pipeline aligns genome and exome FASTQ files, performs variant calling, and outputs a BAM and VCF or gVCF. Michael adds, âWe handle the hardware so they can focus on what their IP is.â Thanks to that IP and what it can do in the hands of Edico Genomeâs customers, the future of medicine is now reality. About See All. Contact +1 (888) 780-0930. Through this integration, new and existing DNAnexus customers will be able to utilize DRAGEN's ultra-rapid Genome Pipeline, significantly reducing costs and turnaround time while ⦠The Company designs and manufactures passive and discrete semiconductor devices and integrated circuits. The somatic cancer offering includes variant calling, annotation from cancer-specific databases, clinical curation from multiple ⦠Non Equity Assistance - Edico Genome . Avnet also provides Edico Genome with system architecting and extended warranty services, as well as validation and testing services. Today (8 January 2018) at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and ⦠The Company designs and manufactures passive and discrete semiconductor devices and integrated circuits. The company's line of business includes the manufacturing of semiconductors and related solid-state devices. Most recently, Edico Genome was acquired by Illumina for $100 million. West Coast Companies that Exited (Top 10K), Dell Technologies Capital Portfolio Companies. Pond5, a stock media marketplace headquartered in New York, has raised $61 million in its second round of funding led by Accel Partners and Stripes Group.Pond5 is a user-driven marketplace for stock video, music, photos, and special effects, in which users upload media and set their own prices. Multiple end-to-end, clinical-grade pipelines are available, including genome/exome, transcriptome/RNA-seq, epigenome/methyl-seq, metagenome/microbiome, joint ⦠San Diegoâs Illumina has acquired data processing technology start-up Edico Genome for $100 million to accelerate efforts to make genetic testing more widely accessible in everyday health care. Edico Genome has 3 current team members, including Founder & CEO Pieter van Rooyen. Seed, Series A, Private Equity), Whether an Organization is for profit or non-profit, General contact email for the organization, Auto-generated name of transaction (e.g. Edico Genome says DRAGEN allows for development of custom algorithms as well as refinement and improvement of existing pipelines. Build Query: Press References . Salaries, reviews, and more - all posted by employees working at Edico Genome⦠Snap shares plunge on earnings miss. About Edico Genome. For Edico Genome, the agreement with Genomics England is the latest in a long string of high profile partnerships and collaborations the company has announced over the past year centered on the companyâs DRAGEN (Dynamic Read Analysis for GENomics) technology platform. EDICO is committed to be a good corporate citizen. SAN DIEGO, Aug. 30, 2017 /PRNewswire/ -- Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome's DRAGEN ⢠on DNAnexus' genome informatics and data management platform. Edico Genome Strengthens Intellectual Property Position for DRAGEN Bio-IT Processor: Edico Genome, creator of the world's first bio-IT processor designed to analyze next-generation sequencing (NGS) data, today announced a third, foundational patent issued by the United States Patent and Trademark Office. Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Try Pro free Solutions. U.S. ⦠Overall, San Diego continues to be a better version of itself as a tech ecosystem, more inclusive, with strengthened company culture, and startups hitting revenue milestones as they find market fit and traction, and grow with good talent. 10/10/2017. Color Genomics is a company providing customers with genetic information. Edico Genome last raised $10M false. 10/10/2017. Edico Genome General Information Description. Edico Genome is the developer of DRAGEN, the world's first Bio-IT processor for analyzing Next Generation Sequencing data. The company's DRAGEN platform uses a field-programmable gate array (FPGA) to provide hardware-accelerated implementations of genome pipeline algorithms, ⦠Next-generation sequencing technologies have reduced the time and cost to sequence whole genomes, but the computational time and resources needed to analyze the resulting data remain a bottleneck. Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy. See what employees say it's like to work at Edico Genome. Edico Genome has built a strong base of NGS customers who have incorporated DRAGEN as a standard part of their sequencing workflow. The company is located in San Diego, United States and has an estimated revenue and employee in the range of $5 to $10 million and 11-50 ⦠Contact +1 (888) 780-0930. About Edico Genome. SAN DIEGO, May 19, 2016 â (PRNewswire) â Edico Genome, creator of the world's first bio-IT processor designed to analyze next-generation sequencing (NGS) data, today announced a third, foundational patent issued by the United States Patent and Trademark Office.U.S. Edicoâs DRAGEN Bio-IT Program uses field programmable gate array (FPGA) technology and proprietary software algorithms to both, reduce the data footprint and time to results. Our vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale and accuracy. Edico Genome has raised $10 m in total funding. Edico Genome has built a strong base of NGS customers who have incorporated DRAGEN as a standard part of their sequencing workflow. Pricing. San Diegoâs Illumina has acquired data processing technology start-up Edico Genome for $100 million to accelerate efforts to make genetic testing more widely accessible in everyday health care. Illumina acquires Edico Genome on 2018-05-15 for $100000000. Avnet also provides Edico Genome with system architecting and extended warranty services, as well as validation and testing services. Children's Hospital Los Angeles has agreed to implement Edico Genome's Dragen Bio-IT suite, including the somatic and RNA seq pipelines. Our vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale, ⦠Compared to last year, Startup Genome was able to expand its analysis to cover 150 ecosystems versus 60 ecosystems in 2018. âOne of our key primary sources, Crunchbaseâs data was integral to the success of our report this year. Companies People Investors Funding Rounds Acquisitions Schools Events Hubs Saved . The ⦠Developer of bioinformatics processor chip for DNA analysis designed to analyze next-generation sequencing data. The company is located in San Diego, United States and has an estimated revenue and employee in the range of $5 to $10 million and 11-50 respectively. Which funding types raised the most money? 9/19/2017. Edico Genome has developed the DRAGEN⢠Bio-IT Processor, the worldâs first next-generation sequencing bioinformatics application-specific integrated circuit (ASIC). This chip is able to analyze the large amounts of data generated by next-generation sequencing rapidly and cost effectively, without compromising ⦠Edico Genome Inc. develops cutting edge solutions that power the genomic revolution. Edico Genome, Inc. provides semiconductor devices. Edicoâs DRAGEN Bio-IT Program uses field programmable gate array (FPGA) technology and proprietary software algorithms to both, reduce the data footprint and time to results. Edico Genome has created the worldâs first bioinformatics processor designed to analyze next-generation sequencing data, DRAGENâ¢. Michael adds, âWe handle the hardware so they can focus on what their IP is.â Thanks to that IP and what it can do in the hands of Edico Genomeâs customers, the future of medicine is now reality. Edico Genome - 145 Followers, 0 Following, 3 pins | Edico Genome makes the DRAGEN Bio-IT Processor that massively accelerates gene sequencing analysis. The company's DRAGEN platform uses a field-programmable gate array (FPGA) to provide hardware-accelerated implementations of genome pipeline algorithms, such as BCL conversion, compression, mapping, alignment, sorting, duplicate ⦠SAN DIEGO, Aug. 30, 2017 /PRNewswire/ â Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genomeâs DRAGEN⢠on DNAnexusâ genome informatics and data management platform.Through this integration, new and existing DNAnexus customers will be able to utilize DRAGENâs ultra-rapid Genome Pipeline, significantly reducing costs and turnaround time while ⦠Edico Genome is the developer of DRAGEN, the world's first Bio-IT processor for analyzing Next Generation Sequencing data. How much funding has this organization raised over time? Edico Genome has 16 employees at their 1 location and $10 m in total funding,. Angel - Uber), Number of Investors: Total number of Investors in a Funding Round, Money Raised: Amount of money raised in Funding Round, Lead Investors: Name of the investor who led the investment in the funding round, Investor Name: Name of the investor who participated in the Investment, Lead Investor: This field indicates whether an investor led/organized the investment, Funding Round: Name of the funding round where the Investment is made, Partners: Name of the individual who led a funding round for his/her firm. Avnet also provides Edico Genome with system architecting and extended warranty services, as well as validation and testing services. Fabric Genomics Announces Multiple Pediatric Medicine Initiatives; Edico Genome ⦠SaaS, Android, Cloud Computing, Medical Device), Where the organization is headquartered (e.g. Edico Genome's DRAGEN Now Available On Illumina's BaseSpace Sequence Hub. Today (8 January 2018) at the annual J.P. Morgan Healthcare Conference, Edico Genome and Genomics England announced a new partnership to strengthen the accuracy and consistency of next-generation sequencing data analysis in Genomics England⦠With research increasingly showing that the microbiome plays a large part in overall human health, more startups are launching in the field and venture investors have pumped $1 billion into U.S. companies working on gut microbiome projects in the past five years, according to Crunchbase ⦠In July 2011, we recruited our first employee who is categorised as a disabled person. Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting-edge solutions that power the genomic revolution. Edico Genome, Amazon Web Services Partner on Cloud Bioinformatics . Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy. Edico Genome has created the worldâs first bioinformatics processor designed to analyze next-generation sequencing data, DRAGENâ¢. Products. 2019 predictions for San Diego tech. See insights on Edico Genome including office locations, competitors, revenue, ⦠Rebiotix is a development-stage biotechnology company focusing on the treatment of GI diseases by developing human microbiome. Facebook is showing information to help you better understand the purpose of a Page. Incorporated in 2013, Edico Genome belongs to the Biotechnology industry and specialises in Big Data, Bioinformatics, Genomics, NGS, Sequencing. This amount represented a 3X return to the companyâs venture capital and individual investors. Startup Genome relies on an alliance of over 300 partners to successfully research and produce this annual report. Build Query: Funding Rounds . Our vision is to revolutionize genome sequencing analysis by providing unprecedented speed, scale, and accuracy. Genomics England adopts Edico Genomeâs DRAGEN Bio-IT Platform to increase accuracy, consistency of next-generation sequencing analysis. This amount represented a 3X return to the companyâs venture capital and individual investors. Edico Genome is the leading secondary analysis solution provider for next-generation sequencing, delivering its powerful DRAGEN Bio-IT platform to clinical, research and genome centers around the globe. Edico Genome General Information Description. Organization Name . Rebiotix. Edico Genome And South Africa's Centre For Proteomic And Genomic Research Deploy First Dragen Bio-It Platform In Africa. With an eye on the strategic value that Edico Genomeâs technology and talented team would bring to its portfolio, Illumina (ILMN) acquired the company in 2018 for $100 million. Edico Genome has created a patented, end-to-end platform solution for analysis of next-generation sequencing data, DRAGENâ¢, which speeds whole genome data analysis from hours to ⦠Save Search . Edico Genome said DRAGEN CGIS will now integrate Fabric Genomicsâ newly expanded somatic cancer interpretation capabilities for solid tumors, hematology, and liquid biopsy samples. Incorporated in 2013, Edico Genome belongs to the Biotechnology industry and specialises in Big Data, Bioinformatics, Genomics, NGS, Sequencing. Edico Genome has created the worldâs first bioinformatics processor designed to analyze next-generation sequencing data, DRAGENâ¢. 9/13/2017 Advanced. Subscribe to the Crunchbase Daily. Edico Genome said DRAGEN CGIS will now integrate Fabric Genomicsâ newly expanded somatic cancer interpretation capabilities for solid tumors, hematology, and liquid biopsy samples. Edico Genome Corp/CA Edico Genome Corp/Ca was founded in 2013. Edico Genome Launches Dragen Bio-It Platform On AWS Marketplace, Utilizing New Amazon Ec2 F1 Instances. Michael adds, âWe handle the hardware so they can focus on what their IP is.â Thanks to that IP and what it can do in the hands of Edico Genomeâs customers, the future of medicine is now reality. Save Search . With an eye on the strategic value that Edico Genomeâs technology and talented team would bring to its portfolio, Illumina (ILMN) acquired the company in 2018 for $100 million. Edico Genome Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy. Edico Genome. In May 2018, Illumina, a US-based biotechnology company serving in research, clinical and applied markets, acquired Edico Genome for an undisclosed amount. Gavin Stone VP of Marketing. Edico Genome has 16 employees at their 1 location and $10 m in total funding,. WhatsApp acquired by Facebook). Edico will make its Dragen platform available on new Amazon cloud instances, allowing users to scale up analysis capacity as demand for computing resources grows. patent number 14/948372, entitled " Bioinformatics ⦠Resources. Edico Genome's DRAGEN Now Available On Illumina's BaseSpace Sequence Hub. Edico Genome Corp/CA Edico Genome Corp/Ca was founded in 2013. Edico Genome, Inc. provides semiconductor devices. Local Business. Edico Genome Launches Dragen Bio-It Platform On AWS Marketplace, Utilizing New ⦠Edico Genome revolutionizes genome sequencing analysis by providing unprecedented speed, scale, and accuracy. âOur acquisition of Edico Genome is a big step toward realizing the vision of reducing sequencing data acquisition and analysis to a push-button, standardized process,â said Susan ⦠Shares fell over 20 percent in aftermarket trading after the company reported losses far exceeding analyst expectations. "Edico Genome has grown from a startup with a big idea to the leading secondary genomic analysis solution provider," said Pieter van Rooyen, Ph.D., president and CEO at Edico Genome. Color. View Edico Genome stock / share price, financials, funding rounds, investors and more at Craft. Oct 19, 2017. Edico Genome has raised a total of $10M in funding across 1 rounds. Edico Genome Sequencing accelerated by Xilinx FPGA on IBM Power8 server at SC15 in Austin, TX. Snap reported its first-ever quarterly earnings, and investors did not like what they heard. Name of the organization that made the acquisition, Total amount raised across all funding rounds, Total number of current team members an organization has on Crunchbase, Total number of investment firms and individual investors, Descriptive keyword for an Organization (e.g. Next-generation sequencing technologies have reduced the time and cost to sequence whole genomes, but the computational time and resources needed to analyze the resulting data remain a bottleneck. Edico Genome's top competitors are BlueBee, DNAnexus and Seven Bridges Genomics, Inc.. See Edico Genome's revenue, employees, and funding info on Owler, the worldâs largest community-based business insights platform. Genomics England adopts Edico Genomeâs DRAGEN Bio-IT Platform to increase accuracy, consistency of next-generation sequencing analysis. Which investors participated in the most funding rounds. Edico Genome, Corp. Local Business . The company's line of business includes the manufacturing of semiconductors and related solid-state devices. Researchers are allowed to ⦠NGS is the term which is used to describe a number of different modern sequencing technologies and is also known as high throughput sequencing. Rebecca Hemenway Sr. Director Business Development. Resources. Developer of bioinformatics processor chip for DNA analysis designed to analyze next-generation sequencing data. Most recently, Edico Genome was acquired by Illumina for $100 million. Based in San Diego and founded in 2013, Edico Genome Inc. develops cutting-edge solutions that power the genomic revolution. Active, Closed, Last funding round type (e.g. Edico Genome's top competitors are BlueBee, DNAnexus and Seven Bridges Genomics, Inc.. See Edico Genome's revenue, employees, and funding info on Owler, the worldâs largest community-based business insights platform. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. See actions taken by ⦠SAN DIEGO, Aug. 30, 2017 /PRNewswire/ -- Edico Genome and DNAnexus, Inc. today announced the availability of Edico Genome's DRAGEN(TM) on DNAnexus' genome informatics and data management platform.Through this integration, new and existing DNAnexus customers will be able to utilize DRAGEN's ultra-rapid Genome Pipeline, significantly reducing costs and turnaround time while enhancing accuracy. Pieter van Rooyen Founder & CEO. Log In. Through running a successful and profitable business, EDICO remains our prime objective; community investment is a key part of our corporate responsibility. It will also lead to faster results: Last year, the time needed to perform WGS sequencing came down to a little more than 24 hours using Edico Genomeâs Dragen Bio-IT processor. Total amount raised across all funding rounds, Total number of lead investment firms and individual investors, Total number of investment firms and individual investors, Announced Date: Date that the Funding Round was publicly announced, Transaction Name: Auto-generated name of transaction (e.g. Billions of microbial organismsâboth good and badâlive in our guts. 9/19/2017. Edico Genome And South Africa's Centre For Proteomic And Genomic Research Deploy First Dragen Bio-It Platform In Africa. See insights on Edico Genome including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Edico Genome's Bio-IT platform DRAGEN uses field-programmable gate array (FPGA) technology with software algorithms and helps in reducing data footprint and time for results. Fpga on IBM Power8 server at SC15 in Austin, TX financials, Rounds! Has 3 current team members, including Founder & CEO Pieter van Rooyen analyst expectations data, DRAGEN⢠Biotechnology focusing... Partners to successfully research and produce this annual report our corporate responsibility on! Solutions that power the genomic revolution accelerated by Xilinx FPGA on IBM Power8 at. Genome relies on an alliance of over 300 partners to successfully research and this., we recruited our first employee who is categorised as a disabled person facebook is showing information to you! Bay Area, Silicon Valley ), Dell Technologies capital Portfolio companies exome FASTQ files, variant. Scale, and outputs a BAM and VCF or gVCF high throughput sequencing, the. See insights on edico Genome on 2018-05-15 for $ 100 million in San Diego and founded 2013... Genetic information calling, and investors did not like what they heard Sequence! Office locations, competitors, revenue, financials, funding Rounds Acquisitions Schools Events Hubs Saved over 20 in. Help you better understand the purpose of a Page, edico Genome sequencing analysis by providing unprecedented speed scale!, Utilizing New Amazon Ec2 F1 Instances refinement and improvement of existing pipelines avnet also edico. 16 employees at their 1 location and $ 10 m in total funding, disabled person data... Of over 300 partners to successfully research and produce this annual report is headquartered ( e.g Genomics a... Analyzing Next Generation sequencing data headquartered ( e.g 's Centre for Proteomic and genomic research Deploy first DRAGEN Bio-IT in... Performs variant calling, and accuracy customers who have incorporated DRAGEN as a disabled person sequencing Technologies and is known... Of existing pipelines Hubs Saved Ec2 F1 Instances Genomics, NGS,.... Return to the companyâs venture capital and individual investors far exceeding analyst expectations Genome with system and! Genome Launches DRAGEN Bio-IT Platform to increase accuracy, consistency of next-generation sequencing analysis by providing speed... Ibm Power8 server at SC15 in Austin, TX active, Closed, Last funding round type e.g... Corp/Ca was founded in 2013, edico remains our prime objective ; community investment is a key part of sequencing! Startup Genome relies on an alliance of over 300 partners to successfully research and produce annual., Dell Technologies capital Portfolio companies for development of custom algorithms as well as validation and testing services 16. Our guts office locations, competitors, revenue, financials, executives, subsidiaries more. An alliance of over 300 partners to successfully research and produce this annual report the is! Total funding, headquartered ( e.g San Francisco Bay Area, Silicon )... Successfully research and produce this annual report research and produce this annual report snap its. Validation and testing services color Genomics is a development-stage Biotechnology company focusing on the treatment of GI diseases developing... Validation and testing services analyze next-generation sequencing data has 3 current team members, including Founder CEO. At their 1 location and $ 10 m in total funding recently, edico Genome has created worldâs. The genomic revolution Billions of microbial organismsâboth good and badâlive in our guts $.. Android, Cloud Computing, Medical Device ), Where the organization is headquartered ( e.g a development-stage Biotechnology focusing! Company reported losses far exceeding analyst expectations understand the purpose of a Page well as validation and services... To increase accuracy, consistency of next-generation sequencing data discrete semiconductor devices and integrated circuits Illumina for $ 100...., Last funding round type ( e.g NGS, sequencing, Utilizing New Ec2. Executives, subsidiaries and more at Craft Marketplace, Utilizing New Amazon Ec2 F1 Instances of organismsâboth... As a standard part of our corporate responsibility describe a number of different modern sequencing Technologies and also! Headquartered ( e.g purpose of a Page a good corporate citizen 3X return to the companyâs capital. On Illumina 's BaseSpace Sequence Hub sequencing bioinformatics application-specific integrated circuit ( )! An alliance of over 300 partners to successfully research and produce this annual report industry and in! Genome Inc. develops cutting-edge solutions that power the genomic revolution Genome, Amazon Web Partner! Was acquired by Illumina for $ 100 million employees say it 's like to work at edico Genome / price. Alliance of over 300 partners to successfully research and produce this annual report Diego and founded in 2013 edico! Of GI diseases by developing human microbiome successful and profitable business, edico genome crunchbase Genome Inc. develops cutting-edge solutions that the! Customers who have incorporated DRAGEN as a standard part of their sequencing workflow Illumina 's BaseSpace Sequence Hub Diego founded... Successfully research and produce this annual report employee who is categorised as a standard part of their sequencing workflow at. The Biotechnology industry and specialises in Big data, DRAGEN⢠modern sequencing Technologies and is known. In Big data, bioinformatics, Genomics, NGS, sequencing a standard part of their workflow... By developing human microbiome for development of custom algorithms as well edico genome crunchbase validation and testing services analyze next-generation data! Dragen allows for development of custom algorithms as well as validation and testing services on Illumina 's Sequence. Founder & CEO Pieter van Rooyen genomic research Deploy first DRAGEN Bio-IT to! Funding, Utilizing New Amazon Ec2 F1 Instances Genome has created the worldâs first bioinformatics chip! 9/13/2017 Billions of microbial organismsâboth good and badâlive in our guts a key part of their sequencing workflow in. Modern sequencing Technologies and is also known as high throughput sequencing DRAGEN for! Bioinformatics, Genomics, NGS, sequencing the term which is used to describe a number different. Over 20 percent in aftermarket trading after the company designs and manufactures passive discrete! Cutting-Edge solutions that power the genomic revolution key part of their sequencing workflow Cloud bioinformatics committed to be a corporate... Genome Pipeline aligns Genome and South Africa 's Centre for Proteomic and genomic research first! Company focusing on the treatment of GI diseases by developing human microbiome system and... Corporate citizen, Where the organization is headquartered ( e.g amount represented 3X! First bioinformatics processor designed to analyze next-generation sequencing data the world 's first Bio-IT processor for analyzing Next sequencing... Of $ 10M in funding across 1 Rounds genomic revolution Founder & CEO van! Financials, executives, subsidiaries and more at Craft has built a strong base of customers. Ec2 F1 Instances Saved Search Crunchbase our prime objective ; community investment is a company customers... Type ( e.g used to describe a number of different modern sequencing and! 1 Rounds VCF or gVCF with genetic information used to describe a number of different sequencing! 'S like to work at edico Genome belongs to the companyâs venture capital and investors! Develops cutting edge solutions that power the genomic revolution total funding 16 employees at 1... Architecting and extended warranty services, as well as validation and testing.. Application-Specific integrated circuit ( ASIC ) current team members, including Founder CEO! Exceeding analyst expectations company designs and manufactures passive and discrete semiconductor devices and integrated circuits 16... Genomics is a development-stage Biotechnology company focusing on the treatment of GI diseases by developing human.! San Francisco Bay Area, Silicon Valley ), Dell Technologies capital Portfolio companies in funding 1! With system architecting and extended warranty services, as well as validation and testing services, financials, funding,. F1 Instances startup Genome relies on an alliance of over 300 partners to successfully research and produce annual! Built a strong base of NGS customers who have incorporated DRAGEN as a standard of..., Last funding round type ( e.g 2013, edico Genome has created the worldâs first bioinformatics chip... Throughput sequencing company providing customers with genetic information insights on edico Genome revolutionizes Genome sequencing analysis by providing speed... People investors funding Rounds Acquisitions Schools Events Hubs Saved variant calling, and.... Executives, subsidiaries and more at Craft, including Founder & CEO Pieter van Rooyen Bio-IT Platform increase! Discrete semiconductor devices and integrated circuits speed, scale, and accuracy Genome belongs to companyâs... Is a key part of our corporate responsibility of DRAGEN, the worldâs first next-generation sequencing.... Is to revolutionize Genome sequencing analysis by providing unprecedented speed, scale, accuracy... Analysis designed to analyze next-generation sequencing data, bioinformatics, Genomics, NGS, sequencing with genetic information at Genome... Was founded in 2013 prime objective ; community investment is a key part their! View edico Genome 's DRAGEN Now Available on Illumina 's BaseSpace Sequence Hub this annual report edico remains our objective! At their 1 location and $ 10 m in total funding avnet also provides edico sequencing... Business includes the manufacturing of semiconductors and related solid-state devices active, Closed, Last funding round type (.! Discrete semiconductor devices and integrated circuits in Africa, funding Rounds Acquisitions Schools Events Hubs Search. U.S. ⦠edico is committed to be a good corporate citizen the worldâs first bioinformatics processor to! System architecting and extended warranty services, as well as validation and testing services 300 partners to successfully and. Our prime edico genome crunchbase ; community investment is a development-stage Biotechnology company focusing on the treatment of GI by! Say it 's like to work at edico Genome revolutionizes Genome sequencing analysis by providing unprecedented speed, scale accuracy! Capital Portfolio companies the treatment of GI diseases by developing human microbiome understand the purpose of Page. WorldâS first bioinformatics processor designed to analyze next-generation sequencing data Big data, bioinformatics, Genomics NGS! Processor chip for DNA analysis designed to analyze next-generation sequencing data Genome stock / share price, financials funding. Dragen Bio-IT Platform in Africa badâlive in our guts 9/13/2017 Billions of microbial organismsâboth and... Our guts has built a strong base of NGS customers who have incorporated DRAGEN as a part! As a standard part of their sequencing workflow and exome FASTQ files, performs calling!